The United States insulin pumps market is expected to grow at a significant rate during the forecast period. The increasing prevalence of diabetes in the United States requires efficient medical devices to examine the insulin level and take steps accordingly. The surge in the adoption of unhealthy eating habits, including consumption of junk food and other high sugar-containing edible items and beverages, is the major cause responsible for increases in the number of diabetic patients in the United States.
A strong economic position and well-developed healthcare infrastructure are expected to influence the market growth. The rise in disposable income among middle-class families is aiding to increase the healthcare expenditure capacity of patients, thereby boosting the demand for insulin pumps in the United States. Insulin pumps do not require the use of needles as conventional insulin measuring devices, which is a major factor attracting patients who are struggling with a daily injecting needle into the body. Insulin pumps stay on the human body and can transfer insulin easily and without causing any pain to the body if the need for additional insulin arises.
The United States insulin pumps market is segmented into type, insulin used, application, end-user, regional distribution, and company. Based on end-user, the market can be divided into hospitals & clinics, diagnostic centers, and home care. The hospitals & clinics segment is expected to dominate the market for the forecast period, 2023-2027. Huge patient in-flow into the hospital facilities and the occurrence of diabetes among the patients is expected to boost the growth of this segment. Favorable reimbursement policies along with increased government spending for the development of hospital facilities are expected to surge the demand for insulin pumps in hospitals & clinics.
The major players operating in the United States insulin pumps market are Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nipro Medical Corporation, among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Objective of the Study
- To analyze the historical growth of the market size of United States insulin pumps market from 2017 to 2020.
- To estimate and forecast the market size of United States insulin pumps market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States insulin pumps market based on type, insulin used, application, end user, regional distribution, and company.
- To identify dominant region or segment in the United States insulin pumps.
- To identify drivers and challenges for United States insulin pumps market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States insulin pumps market.
- To identify and analyze the profile of leading players operating in United States insulin pumps market.
- To identify key sustainable strategies adopted by market players in United States insulin pumps market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Insulin pumps manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to insulin pumps market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | - Type
- Insulin Used
- Application
- End User
|
| Regional scope | South-West, Mid-West, North-East |
| Key companies profiled | Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nipro Medical Corporation. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
